Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haixin Li
Observed names:
H Li,
H. Li
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Tianjin First Center Hospital,
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0009-0007-4993-6554
Observed ORCID:
0009-0007-4993-6554
OpenAlex ID:
A5004237792
An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells
2016
·
Y. Wang
, L. Liu
, et al.
·
Mucosal Immunology
·
155
PDF
Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases
2013
·
F Kong
, J Zhang
, et al.
·
Oncogene
·
13
CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
Cancer Research
·
12
Data from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
1
Evaluation of Raw Cell-Free DNA Sequences for Gastric Cancer Detection
2025
·
Ye Tian
, Yichen Yang
, et al.
·
JCO Precision Oncology
Figure S1 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S4 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S11 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S14 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S10 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S3 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S6 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S7 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S13 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S8 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S2 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S12 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Table S1 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S9 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S5 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
SU‐E‐T‐43: A Methodology for Quality Control of IMPT Treatment Plan Based On VMAT Plan
2015
·
S Jiang
, Y Yang
, et al.
·
Medical Physics
Show more works
View as search
Works count:
21
Citation count:
181
H-index:
3
I10-index:
3
Year
Topic
Type